Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction

NCT00196261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study is to investigate the performance of established and new risk preditors in predicting long term-mortality (up to ten years) of post-infarction patients.

Conditions

  • Infarction, Myocardial

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Georg Schmidt, MD · Deutsches Herzzentrum Muenchen

  • Petra Barthel, MD · Deutsches Herzzentrum Muenchen

  • Axel Bauer, MD · Deutsches Herzzentrum Muenchen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196261 on ClinicalTrials.gov